Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05567952 |
|---|---|
| Brief Title: | A Study to Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir |
| First Submitted : | October 3, 2022 |
| First Submitted that Met QC Criteria : | October 3, 2022 |
| First Posted : | October 5, 2022 |
| Last Update Submitted that Met QC Criteria : | March 25, 2024 |
| Last Update Posted : | March 26, 2024 |